ReviewFrontiers in pharmacology2023

An overview of the past decade of bufalin in the treatment of refractory and drug-resistant cancers: current status, challenges, and future perspectives.

Qingmei Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.